Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Fobi AI (TSXV:FOBI)  launches PulseIR

 John Ballem John Ballem , The Market Herald Canada
0 Comments| January 30, 2023

{{labelSign}}  Favorites
{{errorMessage}}

  • Fobi AI (FOBI) announced the commercial launch of its wholly-owned subsidiary, PulseIR, with the signing of its first customer, PanGenomic Health Inc.
  • PanGenomic offers a self-care digital platform to deliver information about natural and plant-based health treatments
  • PulseIR, which supports Fobi’s IR platform Investor Pass, delivers real-time mobile lock screen communication
  • Fobi AI is a data intelligence company that turns real-time data into actionable insights and personalized customer engagement
  • Fobi AI Stock (TSXV:FOBI) opened trading at C$0.325

Fobi AI (FOBI) announced the commercial launch of its wholly-owned subsidiary, PulseIR, with the signing of its first customer, PanGenomic Health Inc.

PanGenomic offers a self-care digital platform to deliver information about natural and plant-based health treatments. PulseIR is a platform as a service (PaaS) and will generate revenue through an annual license and initial setup fee.

PulseIR, which supports Fobi’s IR platform Investor Pass, delivers real-time mobile lock screen communication. PulseIR delivers a data-driven and digital approach to IR right into the palms of today’s new-age investors providing shareholders with a direct understanding of price action, volume alerts, company news and events.

PulseIR’s go-to-market launch with PanGenomic Health Inc. signifies a milestone growth opportunity as companies across industries look to connect and enhance their existing marketing infrastructure through automation.

Rob Anson, CEO of Fobi, commented on the news.

“There’s no arguing that the world has experienced a major shift towards data-first digital transformation over the last few years. With the launch of PulseIR, we’re providing companies like PanGenomic with the automated tools to deliver a mobilized, data-driven activation and communications channel for investor relations.”

Fobi is a data intelligence company that helps clients turn real-time data into actionable insights and personalized customer engagement to generate increased profits. Fobi partners with some of the largest companies in the world to deliver best-in-class solutions and operates globally in the retail, telecom, sports & entertainment, casino gaming, and hospitality & tourism industries.




{{labelSign}}  Favorites
{{errorMessage}}